The Valley Desk

NCT05005975 · Interventional trial

Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)

Overall registry status Active not recruiting

Phase 3

Conditions EPP, XLP

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov